Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

Fig. 2

Survival curves for all patients by Eastern Cooperative Oncology Group performance status (ECOG). The patients were treated with PEG-L-CHOP every 21 days for 6 cycles. Survival analyses were performed for ECOG using Kaplan-Meier method. Patients with ECOG performance of 2 or high showed less survival rate that patients with ECOG performance of 0~ 1. p = 0.0278 by log-rank test

Back to article page